Clinical Trials Logo

Clinical Trial Summary

The objective of the proposed research is test the feasibility of a brief computer-based personalized feedback intervention to reduce heavy alcohol use among HIV+ individuals. There is a critical need to develop accessible, empirically-supported, low-threshold interventions for HIV+ hazardous alcohol users. The proposed research will develop and evaluate the feasibility, acceptability, and potential efficacy of a novel evidence- and computer-based Personalized Feedback Intervention (PFI) among HIV+ hazardous alcohol users in a high volume Houston HIV clinic.

H1: The PFI group will show increases in self-efficacy, intention to reduce or quit drinking, and decreases in actual drinking, relative to the control group.

H2: Reduced drinking will be associated with less risky sexual behavior, better antiretroviral therapy (ART) medication adherence, and improved HIV quality of life.

H3: Changes in normative perceptions, alcohol use attitudes, self-efficacy for alcohol abstinence, intentions to use, alcohol outcome expectancies, and protective behavioral strategies will mediate intervention effects on drinking behavior. Even if the investigators do not find significant effects on our main outcomes, these will also serve as useful proximal dependent variables that will provide important information regarding the feasibility of this intervention approach in this population.

H4: Intervention effects on drinking outcomes will be stronger for those who report drinking more for social and/or coping reasons.


Clinical Trial Description

The objective of the proposed research is test the feasibility of a brief computer-based personalized feedback intervention to reduce heavy alcohol use among HIV+ individuals. Rates of hazardous alcohol use among HIV+ individuals are approximately two times that found in the general population. Hazardous alcohol use contributes to problems with HIV medication adherence, risky sexual behavior, and psychological problems, as well as physical complications (rapid disease progression, medication toxicities, organ failure, and poor viremic control), which may lead to increased risk of transmission and premature death. Yet, HIV+ hazardous alcohol users remain a hard-to-reach and underserved group. There is therefore a critical need to test alternative approaches to the implementation of effective interventions to reduce HIV disease transmission and progression in HIV+ hazardous alcohol users. One novel and promising intervention approach is the use of personalized feedback, which has consistently been found to be efficacious for reducing hazardous alcohol use across a number of populations. Personalized feedback highlights discrepancies between one's own drinking and typical drinking; reframes use in terms of personal, social, financial, health, and other consequences; and offers strategies for reducing use and alcohol-related negative consequences. The proposed research will develop and evaluate the feasibility, acceptability, and potential efficacy of a novel evidence- and computer-based Personalized Feedback Intervention (PFI) among HIV+ hazardous alcohol users in a high volume Houston HIV clinic. The investigators will recruit 150 HIV+ hazardous alcohol users randomly assigned to receive either PFI or attention-control feedback (e.g., diet, exercise). The investigators expect to demonstrate feasibility and acceptability of the PFI. Outcomes include drinking change processes and behavior, alcohol-related risky sexual behavior, and HIV-related outcomes. An underlying premise, which will be evaluated through the aims, is that the difficulty in reaching hazardous alcohol users who are HIV+ can be addressed with an approach that will not be burdensome to the individuals or to clinic staff. All assessments and procedures will take place in the clinic on tablets or laptop computers. Follow-up assessments will occur at 3 months post-baseline. This research builds on the collaborative work of an experienced team of investigators with complementary expertise supporting all aspects of the proposed research. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03935945
Study type Interventional
Source University of Houston
Contact Clayton Neighbors, PhD
Phone 713-743-2616
Email cneighbors@uh.edu
Status Recruiting
Phase N/A
Start date January 20, 2018
Completion date January 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT05037630 - Feasibility Evaluation of a Self-guided Digital Tool for Problematic Alcohol Use N/A
Completed NCT03037749 - Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence N/A
Enrolling by invitation NCT02927132 - Guilt and Expressive Writing for Reducing Alcohol Use in College Students N/A
Completed NCT02905123 - Brief Internet Intervention for Hazardous Alcohol Use N/A
Enrolling by invitation NCT02952495 - Online Education to Inform the Elderly About Age-related Alcohol Risks Phase 2
Completed NCT01923246 - Development of IVR and WEB Alcohol Interventions N/A
Completed NCT01129804 - Network Support for Alcohol Treatment 2 N/A
Completed NCT00374153 - Southern Methodist Alcohol Research Trial (SMART) N/A
Completed NCT01126164 - Parent Intervention to Reduce Binge Drinking N/A
Completed NCT00383838 - Self-Selected Brief Alcohol Intervention for Adolescents N/A
Completed NCT03408743 - Engineering an Online STI Prevention Program: CSE2 N/A
Recruiting NCT04957628 - AlcoTail - Implementation of Tailored Interventions
Recruiting NCT04164940 - Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems
Completed NCT00292240 - Brief Youth Substance Use Intervention for Primary Care N/A
Completed NCT04804579 - Boston ARCH 4F Intervention to Reduce Fall Risk in People With HIV and Alcohol Use N/A
Completed NCT02387489 - A Clinical Trial of SBIRT Services in School-based Health Centers N/A
Completed NCT02188446 - Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients N/A
Completed NCT01688245 - A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults N/A
Withdrawn NCT01739842 - Kudzu Effects on Brain Ethanol Levels: Proton Spectroscopy Assessment Phase 2/Phase 3
Completed NCT00561587 - Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study Phase 2